Published in J Invest Dermatol on December 01, 2004
Lack of clinical efficacy of imatinib in metastatic melanoma. Br J Cancer (2005) 1.66
c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene (2011) 1.15
Activation of abl family kinases in solid tumors. Genes Cancer (2012) 0.89
Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain. Chem Biol Drug Des (2006) 0.86
Imatinib mesylate for melanoma: will a new target be revealed? J Invest Dermatol (2004) 0.75
Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma. Oncogene (2017) 0.75
Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol (2003) 2.00
Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leuk Res (2007) 1.60
New techniques for the evaluation and therapeutic planning of patients with Klippel-Trénaunay syndrome. J Am Acad Dermatol (2006) 1.42
Pulmonary arterial hypertension in patients with slow-flow vascular malformations. Arch Dermatol (2010) 1.40
Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail (2008) 1.24
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur J Immunol (2008) 1.22
Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica (2011) 1.12
In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells. Blood (2006) 1.08
Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS One (2009) 1.04
Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis. Clin Cancer Res (2004) 1.01
RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood (2003) 1.00
CD28 aptamers as powerful immune response modulators. Mol Ther Nucleic Acids (2013) 0.98
Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion (2009) 0.94
Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. J Invest Dermatol (2007) 0.93
Somatic stem cells and the origin of cancer. Clin Transl Oncol (2006) 0.93
Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? Cardiovasc Res (2006) 0.84
Ultrasound-guided injection of polidocanol microfoam in the management of venous leg ulcers. Arch Dermatol (2004) 0.84
MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia. Cell Transplant (2010) 0.83
Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery. Arch Dermatol (2008) 0.82
BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia. Br J Haematol (2008) 0.82
[Update in the treatment of herpes zoster]. Actas Dermosifiliogr (2006) 0.82
Culture of human bone marrow-derived mesenchymal stem cells on of poly(L-lactic acid) scaffolds: potential application for the tissue engineering of cartilage. Knee Surg Sports Traumatol Arthrosc (2012) 0.81
Dendritic cell vaccination in glioblastoma after fluorescence-guided resection. World J Clin Oncol (2012) 0.80
Adverse reactions after nonablative radiofrequency: follow-up of 290 patients. J Cosmet Dermatol (2007) 0.79
Three-dimensional histology for dermatofibrosarcoma protuberans: case series and surgical technique. J Am Acad Dermatol (2012) 0.79
The hidden face of venous malformations: a multidisciplinary therapeutic approach. Arch Dermatol (2008) 0.79
Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica (2003) 0.78
Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations. J Am Acad Dermatol (2004) 0.78
Klebsiella pneumoniae and leukocytoclastic vasculitis. Lancet (2002) 0.78
Mechanical properties of cross-linked collagen meshes after human adipose derived stromal cells seeding. J Biomed Mater Res A (2010) 0.78
Indirect MR venography for evaluation and therapy planning of patients with Klippel-Trenaunay syndrome. AJR Am J Roentgenol (2010) 0.75
Microfoam treatment of Klippel-Trénaunay syndrome and vascular malformations. J Am Acad Dermatol (2008) 0.75
Aggressive tumors of the concha: treatment with postauricular island pedicle flap. J Cutan Med Surg (2004) 0.75
BiovaxID®: a customized idiotype vaccine for the treatment of B-cell lymphoma. Expert Rev Vaccines (2011) 0.75
Cardiovascular risk in women attending primary care centres: baseline data of the EVA study. Nephrol Dial Transplant (2012) 0.75
'Skin popping' ulceration in an HIV patient. Successful treatment with antiretroviral drugs and stanozolol. Int J STD AIDS (2002) 0.75
Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib. Cancer Genet Cytogenet (2005) 0.75
Images in clinical medicine. Enlarged pinna. N Engl J Med (2015) 0.75
Mixed skin ulcers misdiagnosed as pyoderma gangrenosum and rheumatoid ulcer: successful treatment with ultrasound-guided injection of polidocanol microfoam. Dermatol Surg (2006) 0.75
Torpid ulcer on the achilles tendon: conservative treatment with stanozolol and pinch grafting. Plast Reconstr Surg (2003) 0.75
Topical imiquimod for Bowenoid papulosis in an HIV-positive woman. Acta Derm Venereol (2002) 0.75
Lymph node false-positive FDG-PET after recent surgery in primary melanoma. Acta Derm Venereol (2004) 0.75
Familial dermatofibrosarcoma protuberans: a nonfortuitous association? Dermatol Surg (2013) 0.75
Animal model to explain fat atrophy using nonablative radiofrequency. Dermatol Surg (2007) 0.75
Are cutaneous vessels one of the targets of resurfacing with photodynamic therapy? J Cosmet Dermatol (2008) 0.75